Healthcare -
Biotechnology - NASDAQ - US
$ 1.89
-0.526 %
$ 141 M
Market Cap
-1.63
P/E
IKT - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative IKT - Inhibikase Therapeutics, Inc.
11.4 M
LAST VALUE
35.29%
2 YEAR CAGR
21.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR